EDAP-TMS FRANCE

Location

AUVERGNE RHONE ALPES

Founded

1994-02-23

Risk Signals

28 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about EDAP-TMS FRANCE

Live alerts from global media, monitored by Business Radar

EDAP TMS 6K Current report | EDAP 27 Mar 25

2025-03-28 (capedge.com)

EDAP TMS 6K Current report | EDAP 27 Mar 25

Current report (foreign), 6-K SEC filing by EDAP TMS on 27 Mar 25, 7:41am

Read more
Glen French Joins EDAP's Board of Directors - Medical Product Outsourcing

2025-03-21 (mpo-mag.com)

Glen French Joins EDAP's Board of Directors - Medical Product Outsourcing

Former Boston Scientific and Pulmonix Corporation executive Glen French has been appointed to EDAP's Board of Directors.

Read more
EDAP Appoints Glen French to Board of Directors

2025-03-03 (globenewswire.com)

EDAP Appoints Glen French to Board of Directors

PDF Version Lyon, France, March 3, 2025 -- Edap tms sa (nasdaq: Edap) ("The Company" or "EDAP"), the Global Leader in Robotic Energy-Based Therapies,.

Read more
EDAP Appoints Glen French to Board of Directors |

2025-03-03 (manilatimes.net)

EDAP Appoints Glen French to Board of Directors |

PDF Version

Read more
HIFU Trial Breakthrough For Pancreatic Cancer Treatment

2025-01-16 (distilinfo.com)

HIFU Trial Breakthrough For Pancreatic Cancer Treatment

EDAP TMS SA has initiated a groundbreaking Phase I/II PULS Trial using High Intensity Focused Ultrasound (HIFU) technology to treat pancreatic tumors, marking a significant advancement in cancer treatment. The trial, conducted at Centre Léon Bérard in France, aims to evaluate the safety and efficacy of this innovative therapy for patients with locally advanced and unresectable pancreatic tumors.

Read more
Focal One completes study to expand access to robotic prostate cancer treatment -

2024-12-31 (therobotreport.com)

Focal One completes study to expand access to robotic prostate cancer treatment -

The study found that Focal One's treatment methods match up with the gold star standard of surgery, and improve quality of life outcomes.

Read more
EDAP TMS publishes results of cancer treatment through robotic system – Robotics & Automation News

2024-12-09 (roboticsandautomationnews.com)

EDAP TMS publishes results of cancer treatment through robotic system – Robotics & Automation News

EDAP TMS, a provider of robotic energy-based therapies, has published the full results from the HIFI study in the prestigious, peer-reviewed journal, European Urology, which has the highest impact …

Read more
Transcript : EDAP TMS S.A., Q2 2024 Earnings Call, Aug 28, 2024

2024-08-28 (marketscreener.com)

Transcript : EDAP TMS S.A., Q2 2024 Earnings Call, Aug 28, 2024

Presentation Operator MessageOperator Good day, and welcome to the EDAP TMS Second Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now...

Read more
EDAP TMS S.A. Announces Resignation of Marc Oczachowski as Chairman of Board of Directors, Effective September 30, 2024

2024-08-28 (marketscreener.com)

EDAP TMS S.A. Announces Resignation of Marc Oczachowski as Chairman of Board of Directors, Effective September 30, 2024

EDAP TMS S.A. announced on August 27, 2024, Marc Oczachowski resigned as Chairman of the Company?s Board of Directors in order to allow him more time to focus on other endeavors. In order to provide...

Read more

Never miss a headline about EDAP-TMS FRANCE

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages